In the case of acute myeloid leukemia (AML), our group has identified and characterized the leukemia-associated antigen, PR1, a nonameric, HLA-A2-restricted peptide derived from serine proteases proteinase 3 and neutrophil elastase (7–9). The gene discussed is PRTN3; the disease is acute myeloid leukemia.